Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1994-9-27
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0160-6689
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
312
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8071293-Adult,
pubmed-meshheading:8071293-Clozapine,
pubmed-meshheading:8071293-Haloperidol,
pubmed-meshheading:8071293-Humans,
pubmed-meshheading:8071293-Male,
pubmed-meshheading:8071293-Obsessive-Compulsive Disorder,
pubmed-meshheading:8071293-Schizophrenia,
pubmed-meshheading:8071293-Schizophrenic Psychology
|
pubmed:year |
1994
|
pubmed:articleTitle |
More on obsessive-compulsive symptoms and clozapine.
|
pubmed:publicationType |
Letter,
Comment,
Case Reports
|